NHS National Proprietary Pharmaceuticals - Low Molecular Weight Heparins and Fondaparinux Products
What the buyer wrote
NHS National Proprietary Pharmaceuticals – Low Molecular Weight Heparins and Fondaparinux Products – CM/PHR/22/5732 Period of Framework Agreement: 1 March 2026 to 29 February 2028 with an option or option(s) to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.
Bid for this and lost? There is a short window in which the decision can be questioned.
Awarded to
Details
- What the buyer calls it
- NHS National Proprietary Pharmaceuticals - Low Molecular Weight Heparins and Fondaparinux Products
- How they are buying
- Advertised, open to anyoneAny supplier could bid without being invited first.
- Type
- goods
- Framework
- Yes: joining it lets you bid for call-offs without a new tender each time
- Work starts
- 1 Mar 2026
- Work ends
- 29 Feb 2028
- Where
- in the North East, in the North West, in the East Midlands, in the West Midlands, in the East of England, in the South East, in the South West, in London, in Yorkshire and The Humber
- Kind of work
- Pharmacy and medicines
Who the buyer named
Julian Farley - Procurement Manager was the named contact on this notice. Questions closed on 15 Oct 2025, 17:00 BST.